Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1

Molekulyarnaya Biologiya

Volumn 37, Issue 3, 2003, Pages 404-408

  Zotova, E V ^a   Chistyakov, D A ^a   Savost'yanov, K V ^a   Bursa, T R ^b   Galeev, I V ^b   Strokov, I A ^b   Nosikov, V V ^c  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b Russian Medical Academy of Postgraduate Education   (Russian Federation)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLYCEROL; SUPEROXIDE DISMUTASE; VALINE; ALANINE; GLYCINE; MANGANESE SUPEROXIDE DISMUTASE; SOD3 PROTEIN, HUMAN;

ALLELE; ARTICLE; DIABETIC NEUROPATHY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; ADOLESCENT; ADULT; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALANINE; ARGININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLYCINE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE; VALINE;

EID: 0141834164     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zhu M., Spink D.C., Yan B., Bank S., DeCaprio A.P. 1994. Formation and structure of cross-linking and monomeric pyrrole autooxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein. Chem. Res. Toxical. 7, 551-558.
2. Cameron N.E., Cotter M.A. 1997. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 46, 31-37.
3. Kumar J.S., Menon V.P. 1992. Peroxidative changes in experimental diabetes mellitus. Indian J. Med. Res. 96, 176-181.
4. Van Dam P.S., Van Asbeck B.S., Erkelens D.W., Marx J.J.M., Gispen W.-H., Bravenboer B. 1995. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes metabolism reviews. 11, 181-192.
5. Van Dam P.S., Van Asbeck B.S., Bravenboer B., Van Oirschot J.F., Marx J.J.M., Gispen W.-H. 1999. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration. Metabolism. 48, 442-447.
6. Martinez-Blasco A., Bosch-Morell F., Trenor C., Romero F.J. 1998. Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved. Biofactors. 8, 41-43.
7. Marklund S.L. 1990. Analysis of extracellular superoxide dismutase in tissue homogenates and extracellular fiuids. Methods Enzymol. 186, 260-265.
8. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimiz Y., Mizino Y. 1996. Structural dimorphism in the mitocnondrial argeting sequence in the human manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun. 226, 561-565.
9. Shimoda-Matsubayashi S., Hattori Y., Matsumine H., Shinohara A., Yoritaka A., Mori H., Kondo T., Chiba M., Mizuno Y. 1997. MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology. 49, 1257-1262.
10. Rosenblum J.S., Gilla N.B., Lerner R.A. 1996. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. USA. 93, 4471-4473.
11. Sandstrom J., Nilson P., Karlsson K., Marklund S.L. 1994. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J. Biol. Chem. 269, 19163-19166.
12. Folz R.J., Peno-Green L., Grapo J.D. 1994. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum. Mol. Genet. 12, 2251-2254.
13. Yamada H., Yamada Y., Adachi T., Goto H., Ogasawara N., Futenma A., Kitano M., Hirano K., Kato K. 1995. Molecular analysis of extracellular- superoxide dismutase gene associated with high level in serum. Jpn. Hum. Genet. 40, 177-184.
14. Sakashita N., Ando Y., Marklund S.L., Nilsson P., Tashima K., Yamashita T., Takahashi K. 1998. Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report. Hum. Pathol. 29, 1169-1172.
15. Dyck P.J., Melton J.L., O'Brien P.C., Service F.G. 1997. Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy Study. Diabetes. 46, 5-8.
16. Budowle B., Baechtel F.S. 1990. Modifications to improve the effectiveness of restriction fragment length polymorphism. Appl. Electrophor. 1, 181-187.
17. Chistyakov D.A., Savost'anov K.V., Zotova E.V., Strokov I.A., Nosikov V.V. 2001. Polymorphisms at the SOD2 and SOD3 genes and their relation to diabetic neuropathy in type 1 diabetes mellitus. BMC Medical Genetics. 2, 4-11.
18. Hutchon D.J.R. http:// Calculator for confidence intervals for odds ratio unmatched case control study.
19. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., Kimura A. 1999. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem. Biophys. Res. Commun. 261, 332-339.
20. Marklund S.L. 1984. Extracellular superoxide dismutase in human tissues and human cell lines. Clin. Invest. 74, 1398-1403.
21. Wang X.L., Adachi T., Sim A.S., Wilcken D.E. 1998. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Atheroscler. Thromb. Vasc. Biol. 18, 1915-1921.